November 28, 2016
The NanoAssemblr® Blaze is enabling for researchers and drug development programs. The dynamic volume range allows researchers to use the Blaze for nanoparticle discovery, for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) studies. The NanoAssemblr Blaze was developed to bridge the gap between nanoparticle discovery and clinical development. The Blaze can manufacture between 10 mL and 1 L per batch. Nanoparticles made on Precision NanoSystems’ Benchtop instrument scale seamlessly to the Blaze with minimum process development accelerating transfer of nanoparticle candidates towards clinical development.